Lorenzo Leggio, MD, PhD

NIDA Clinical Director and Deputy Scientific Director · 2 sessions at 1 meeting · 1 upcoming

Topics

Alcohol Use Disorder (2)GLP-1 & Metabolic Psychiatry (2)Substance Use Disorders (2)

Sessions

AAAP 37th Annual Meeting and Scientific Symposium

November 12–15, 2026 · Memphis, TN · Full program

  • SymposiumFrom Metabolism to Addictions: Repurposing GLP-1 Therapies for Alcohol and Other Substance Use Disorders

    Surveys preclinical and emerging clinical evidence for GLP-1 receptor agonists as candidate treatments for alcohol and other substance use disorders.

    Alcohol Use DisorderGLP-1 & Metabolic PsychiatrySubstance Use Disorders

  • SymposiumChairSymposium I - From Metabolism to Addictions: Repurposing GLP-1 Therapies for Alcohol and Other Substance Use Disorders

    November 12, 2026, 09:00–10:40

    Reviews preclinical, observational and early randomized trial evidence on using GLP-1 receptor agonists to treat alcohol and other substance use disorders, including psychiatric safety.

    Alcohol Use DisorderGLP-1 & Metabolic PsychiatrySubstance Use Disorders

Presents with

Joji Suzuki (2) · Luba Yammine (2) · Manish Jha (2)

Speaker listings come from official conference programs and may change — confirm on each meeting's site. Spot an error? Names printed differently on different programs are merged conservatively.

Is this you? Add your photo

Send us a headshot and we'll show it on this page and next to your sessions. Every submission is reviewed by a person before it goes live; we never share your email.

Browse the directory

By date

By specialty

By location

By type

By audience

Speakers & topics

Recurring meetings